Your browser doesn't support javascript.
loading
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
Haddad, Tufia C; D'Assoro, Antonino; Suman, Vera; Opyrchal, Mateusz; Peethambaram, Prema; Liu, Minetta C; Goetz, Matthew P; Ingle, James N.
Afiliación
  • Haddad TC; Division of Medical Oncology, Mayo Clinic, 200 First Street S.W., Rochester, MN, 55905, USA. haddad.tufia@mayo.edu.
  • D'Assoro A; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Suman V; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA.
  • Opyrchal M; Division of Oncology, Roswell Park Cancer Center, Buffalo, NY, USA.
  • Peethambaram P; Division of Medical Oncology, Mayo Clinic, 200 First Street S.W., Rochester, MN, 55905, USA.
  • Liu MC; Division of Medical Oncology, Mayo Clinic, 200 First Street S.W., Rochester, MN, 55905, USA.
  • Goetz MP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Ingle JN; Division of Medical Oncology, Mayo Clinic, 200 First Street S.W., Rochester, MN, 55905, USA.
Breast Cancer Res Treat ; 168(3): 639-647, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29289986
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Azepinas / Neoplasias de la Mama / Relación Dosis-Respuesta a Droga / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Azepinas / Neoplasias de la Mama / Relación Dosis-Respuesta a Droga / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article